300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Artificial Intelligence
Retail
Oil and Gas
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Japan
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Asia
Dominican Republic
Bermuda
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Ames Seed Capital, VC Fund

Ames Seed Capital

VC Fund

Ames, United States

Ames Seed Capital is a pool of private investors.

Total investments:
6
Last investment:
Lead investor:
33%

Last updated:

Industries Ames Seed Capital invests in

PetHealth CareB2BSaaSAgTech

Stages Ames Seed Capital invests in

SeedSeries BSeries CConvertible Note

Countries Ames Seed Capital invests in

United StatesCanada

Round sizes

Seed $100k–$1.2M

Round size

Seed
$100k–$1.2M

Investment Focus

Industry

  • Pet 2 (33%)
  • Health Care 2 (33%)
  • B2B 1 (17%)
  • SaaS 1 (17%)
  • AgTech 1 (17%)
See all 18 industries →

Stage

  • Seed 3 (50%)
  • Series B 1 (17%)
  • Series C 1 (17%)
  • Convertible Note 1 (17%)

Country

  • United States 4 (67%)
  • Canada 1 (17%)

Investments

CompanyDescriptionRoundLinks
VetMeasure VetMeasure
VetMeasure is a developer of a wearable animal health technology harness device designed to remotely monitor health conditions in dogs. The company's device provides accurate detection of an animal's health statistics in real-time, enabling veterinarians and owners to monitor an animal's heart and pulse rates, respiration bodytemperature, and humidity to determine an animal's condition following surgical procedures or illnesses. $100K / Seed / Aug 12, 2019
Pitchly Pitchly
Pitchly provides a SaaS platform for non-technical users to create data-infused real-time PowerPoint and Word documents linked to internal business data wherever it may live. Typically, before Pitchly, this work takes place in disconnected and inefficient tools like Excel, Word, PowerPoint, Sharepoint, or IT-owned databases. The platform aggregatesdisparate information sources, making information easy to catalog, find, and produce compelling and relevant data-driven Word and PowerPoint documents. This generates a 93% reduction in time to create data-heavy documents with 100% error reduction; all in half the time it takes to locate information when compared to traditional approaches.Pitchly end-users can even create custom forms to populate data to those original sources to make certain their teams are using the most relevant and up-to-date data. It aggregates digital data sources, such as Excel, SQL, Salesforce, and more, into one normalized tabular view of the data to reference, search, filter, and then integrate into documents and presentations in real-time. The platform gives the ability to easily publish select information from your database(s) on a website, in various digital forms.The company was founded in 2014 and is headquartered in Des Moines, Iowa. $650K / Convertible Note / Mar 31, 2019
automed automed
A world first, automed is paving the way forward for livestock producers of all sizes. With one single system, you can automatically calculate, deliver and record livestock treatments, and effectively manage your operation. Powerful and easy to use, the automed system integrates easily with existing livestock tools and farm management systems. Theautomed device automatically calculates and delivers both fixed and weight based treatments simply by synchronizing with the automed app. $400K / Seed / Aug 01, 2018
FindBoB FindBoB
FindBoB is a growth, transition and succession planning tool for financial advisors and insurance agents, utilizing machine learning and elements of gamification for asset protection. $1.2M / Seed / Dec 22, 2017
NewLink Genetics NewLink Genetics
NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer.Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals andphysician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day. $17M / Series C / Jan 31, 2008
NewLink Genetics NewLink Genetics
NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer.Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals andphysician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day. $8.2M / Series B / Sep 07, 2007

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Artificial Intelligence
Retail
Oil and Gas
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Japan
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Asia
Dominican Republic
Bermuda
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Ames Seed Capital invest in?

Ames Seed Capital invests primarily in Pet, Health Care and B2B startups, most often at Seed and Series B stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Ames Seed Capital invest in?

Ames Seed Capital typically joins rounds of $100k–$1.2M at Seed. These are whole funding-round sizes, not Ames Seed Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Ames Seed Capital took part in.

When did Ames Seed Capital last invest?

The most recent investment recorded for Ames Seed Capital closed in Aug 2019. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Ames Seed Capital Ames Seed Capital Find emails